MTD:NYE-Mettler-Toledo International Inc (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 1478.92

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.14M

Analyst Target

USD 865.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

N/A

USD 198.03B
IQV IQVIA Holdings Inc

N/A

USD 44.14B
A Agilent Technologies Inc

N/A

USD 42.54B
LH Laboratory Corporation of Amer..

N/A

USD 18.52B
DGX Quest Diagnostics Incorporated

N/A

USD 17.19B
CRL Charles River Laboratories

N/A

USD 10.65B
QGEN Qiagen NV

N/A

USD 10.05B
ENZ Enzo Biochem Inc

N/A

USD 0.06B
VNRX Volitionrx Ltd

N/A

USD 0.06B
TMO Thermo Fisher Scientific Inc

N/A

N/A

ETFs Containing MTD

MCSE Martin Currie Sustainable.. 5.12 % 0.00 %

N/A

N/A
EPRE 4.58 % 0.00 %

N/A

N/A
IBB iShares Biotechnology ETF 3.05 % 0.47 %

N/A

USD 7.60B
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.39 % 0.00 %

N/A

N/A
BMED BlackRock Future Health E.. 2.35 % 0.00 %

N/A

USD 4.21M
XMLC:F L&G Clean Water UCITS ETF 2.27 % 0.00 %

N/A

N/A
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.19 % 0.00 %

N/A

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.19 % 0.00 %

N/A

N/A
XLVE:CA Mulvihill U.S. Health Car.. 1.82 % 0.00 %

N/A

N/A
ZHU:CA BMO Equal Weight US Healt.. 1.69 % 0.00 %

N/A

CAD 0.01B
HECO 0.00 % 0.95 %

N/A

N/A
QRI:CA 0.00 % 1.06 %

N/A

N/A
YXM.B:CA 0.00 % 0.69 %

N/A

N/A
ZUH:CA BMO Equal Weight US Healt.. 0.00 % 0.39 %

N/A

CAD 0.27B
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.93% 92% A 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.93% 92% A 80% B-
Trailing 12 Months  
Capital Gain 33.47% 92% A 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.47% 92% A 78% C+
Trailing 5 Years  
Capital Gain 109.95% 83% B 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 109.95% 83% B 86% B+
Average Annual (5 Year Horizon)  
Capital Gain 16.66% N/A N/A 80% B-
Dividend Return 16.66% N/A N/A 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 30.83% N/A N/A 33% F
Risk Adjusted Return 54.03% N/A N/A 71% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike